ArticleFrontiers in immunology2023

CDR2 and CDR2L line blot performance in PCA-1/anti-Yo paraneoplastic autoimmunity.

Nisa Vorasoot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.